Hikma Pharmaceuticals Aktie
18,30
EUR
+0,20
EUR
+1,10
%
16,74
CHF
+0,29
CHF
+1,78
%
Werbung
Hikma Pharmaceuticals Aktie Analyse
| 14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
| 15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
| 10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
| 21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung